Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Otsuka breaks up with cancer candidates on strategic grounds
Fierce Biotech
Friday, February 14, 2025 - 9:22am
tags:
Otsuka, cancer, CAR-T
Bristol Myers Squibb comes up short in bid to expand Opdualag in melanoma
Fierce Pharma
Friday, February 14, 2025 - 9:21am
tags:
Bristol Myers Squibb, Opdualag, melanoma, clinical trials
Medtronic & Boston Scientific’s Axonics End Patent Battle
Medical Devices and Diagnostics Industry
Friday, February 14, 2025 - 9:20am
tags:
Medtronic, Boston Scientific, Medtech, patents, sacral neuromodulation
Corbus posts first US data on challenger to Pfizer’s ADC Padcev
Fierce Biotech
Friday, February 14, 2025 - 9:18am
tags:
Corbus Pharmaceuticals, Pfizer, Padcev, antibody-drug conjugate, clinical trials
ExpressionEdits and Boehringer Ingelheim partner to optimize gene therapies
Pharmaceutical Business Review
Friday, February 14, 2025 - 9:15am
tags:
Boehringer Ingelheim, ExpressionEdits, gene therapy
First self-amplifying mRNA vaccine reaches Europe
Pharmaphorum
Friday, February 14, 2025 - 9:15am
tags:
Arcturus Therapeutics, vaccines, MRNA, Europe, Kostaive, COVID-19, CSL
Genentech archives diversity reports amid site update, examines ‘potential implications of executive orders’
Fierce Biotech
Thursday, February 13, 2025 - 10:08pm
tags:
Roche, Genentech, diversity, DEI, Donald Trump
Selkirk Pharma introduces new service for rapid delivery of trial supplies
Clinical Trials Arena
Thursday, February 13, 2025 - 9:51pm
tags:
Selkirk Pharma, ClinFAST, clinical trials
Galapagos drops one CD19 CAR-T to focus on 'flagship' program
Fierce Biotech
Thursday, February 13, 2025 - 9:48pm
tags:
Galapagos, CAR-T, GLPG5201, CLL
Amgen ends Ideaya cancer combination trial after partner unveils rival molecule
Fierce Biotech
Thursday, February 13, 2025 - 9:45pm
tags:
Amgen, IDEAYA Biosciences, AMG 193, cancer
Moderna trims digital team, lays off employees as chief information officer departs
Fierce Pharma
Thursday, February 13, 2025 - 9:42pm
tags:
Moderna Therapeutics, layoffs, digital
A brain biotech launches with Roche’s spare parts
BioPharma Dive
Thursday, February 13, 2025 - 9:36pm
tags:
Roche, Newleos Therapeutics, funding, mental health
Is J&J Going to Sell its Stroke Business?
Medical Devices and Diagnostics Industry
Thursday, February 13, 2025 - 11:57am
tags:
JNJ, Medtech, stroke, Cerenovus, M&A
Senate confirms RFK Jr. as Health and Human Services secretary
MSN
Thursday, February 13, 2025 - 11:55am
tags:
Robert F Kennedy Jr., HHS, Donald Trump, Senate
Alto Neuroscience reports positive outcomes from Phase IIb trial of MDD therapy
Clinical Trials Arena
Thursday, February 13, 2025 - 11:49am
tags:
Alto Neuroscience, ALTO-300, major depressive disorder, clinical trials
Aardvark prices $94M IPO to fund Prader-Willi, obesity drug work
BioPharma Dive
Thursday, February 13, 2025 - 11:46am
tags:
Aardvark Therapeutics, IPOs, Prader-Willi Syndrome
Pfizer outlines Talzenna's survival benefit in bid for broad prostate cancer approval
Fierce Pharma
Thursday, February 13, 2025 - 11:43am
tags:
Pfizer, Talzenna, prostate cancer
Medtronic buys Nanovis’ nano technology for use in spine implants
Medtech Dive
Thursday, February 13, 2025 - 11:42am
tags:
Medtech, Medtronic, Nanovis, spinal implants
Top N.I.H. Official Abruptly Resigns as Trump Orders Deep Cuts
NY Times, NY
Thursday, February 13, 2025 - 11:41am
tags:
NIH, Donald Trump, Dr. Lawrence Tabak
Salesforce or Veeva: How drugmakers can navigate the upcoming CRM split
Pharma Voice
Thursday, February 13, 2025 - 11:39am
tags:
Veeva, Salesforce, CRM

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.